Xiayang Ren

Cardiovascular toxicity associated with angiogenesis inhibitors: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System database from 2014 to 2021

Yanfeng Wang, Chanjuan Cui, Xiayang Ren et al. · Frontiers in Cardiovascular Medicine · 2022 · 25 citations · Full text

Cardiovascular toxicity profiles of immune checkpoint inhibitors with or without angiogenesis inhibitors: a real-world pharmacovigilance analysis based on the FAERS database from 2014 to 2022

Yanfeng Wang, Chanjuan Cui, Lei Deng et al. · Frontiers in Immunology · 2023 · 21 citations · Full text

Immune-related interstitial lung disease induced by different immune checkpoint inhibitors regimens: A real-world study from 2014 to 2022 based on FAERS databases

Chanjuan Cui, Siyu Zhang, Xiayang Ren et al. · European Journal of Pharmacology · 2023 · 13 citations

Respiratory system toxicity induced by immune checkpoint inhibitors: A real-world study based on the FDA adverse event reporting system database

Chanjuan Cui, Lei Deng, Wenqing Wang et al. · Frontiers in Oncology · 2022 · 10 citations · Full text

Haematopoietic cytopenia associated with cyclin-dependent kinase 4/6 inhibitors: A real-world study of data from the food and drug administration adverse event reporting system database

Xiayang Ren, Cilin Yan, Le Tian et al. · International Journal of Immunopathology and Pharmacology · 2022 · 10 citations · Full text